LeapFrog Closes $1B Fund Targeting Companies in Emerging Markets
TLDR
- LeapFrog Investments closes Fund IV above $1 billion target, with $1.02 billion in commitments for scaling healthcare and financial services companies in growth markets.
- Key investors in Fund IV include Temasek, AIA, Prudential Financial, European Investment Bank, and U.S. International Development Finance Corporation.
- Fund IV boasts contributions from global asset managers, strategic healthcare investor Eli Lilly, and foundations like the Ford Foundation.
LeapFrog Investments has closed its fourth fund (Fund IV) with commitments and designated co-investments totaling $1.02 billion, surpassing its $1 billion target.
The fund includes $808 million in primary commitments and $210 million for co-investments aimed at scaling high-impact healthcare and financial services companies in global growth markets.
Key investors include Temasek, AIA, Prudential Financial, the European Investment Bank, the U.S. International Development Finance Corporation, and others. Global asset managers like Sumitomo Mitsui Trust Bank, strategic healthcare investor Eli Lilly, and foundations such as the Ford Foundation also contributed.
You can follow Daba’s reporting on Africa on WhatsApp. Sign up here
Key Takeaways
LeapFrog’s Fund IV reflects growing investor confidence in impact-driven private equity. By targeting healthcare and financial services in high-growth markets, the fund aims to generate competitive returns while improving millions of lives. Its success underscores the rising demand for sustainable, purpose-driven investments in emerging economies.
Think someone else should see this?
To invest in this opportunity and other opportunities across Africa
Download the daba finance app on your mobile through
Take action.
Download app
Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.
Partner with us
Unlock exciting business opportunities and growth potential.
Join Daba
Become a part of our vibrant community and enjoy exclusive benefits.
Contact us
Reach out to us for inquiries, support, or collaboration.